Table 6: Median (25th, 75th quartile) content of selected polyunsaturated fatty acids and ratio -3/ -6 fatty acids in diet and plasma phospholipids (PL) in colorectal cancer patients, separated by Dukes stage and ( )a.

Dukes stage
A + B ( )C + D ( ) value

Diet (g/day)
  Dietary 20:4 -6 (AA)0.13 (0.11, 0.15)0.15 (0.11, 0.20)0.13
  Dietary 20:5 -3 (EPA)0.26 (0.18, 0.37)0.34 (0.24, 0.53)0.10
  Dietary 22:6 -3 (DHA)0.45 (0.33, 0.58)0.56 (0.44, 0.94)0.02
  Sum dietary EPA + DHA0.72 (0.50, 0.94)0.88 (0.68, 1.49)0.04
  Ratio dietary -3/ -6 fatty acids0.18 (0.16, 0.21)0.21 (0.18, 0.27)0.007
Plasma PL (g/100 g)
  Plasma PL 20:4 -6 (AA)9.2 (7.7, 10.8)9.3 (8.0, 10.5)0.85
  Plasma PL 20:5 -3 (EPA)1.2 (1.0, 1.7)1.5 (1.1, 2.2)0.30
  Plasma PL 22:6 -3 (DHA)5.4 (4.4, 6.7)6.0 (5.0, 7.2)0.20
  Sum plasma PL EPA + DHA6.7 (5.8, 7.7)7.6 (6.0, 9.4)0.17
  Ratio plasma PL -3/ -6 fatty acids0.25 (0.18, 0.28)0.26 (0.20, 0.35)0.32

aAbbreviation is as follows: PL: phospholipids.